Polyvinylpyrrolidone (PVP) Market By Polymer Grade (Low K-Value PVP [K12–K17], Medium K-Value PVP [K18–K60], High K-Value PVP [Above K60]); By Primary Application (Pharmaceutical Tablet Binding & Solid Dosage, Pharmaceutical Solubilization & Other Dosage Forms, Hair Styling Products, Other Personal Care & Cosmetics, Adhesives & Coatings, Membrane Manufacturing, Other Industrial Processing, Oral Care Formulations, Other Specialty Applications); By End-Use Industry (Pharmaceuticals, Personal Care & Cosmetics, Industrial Manufacturing, Other Specialty End Uses); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

How Large Is the Global Polyvinylpyrrolidone Market, and What Is Driving Its Growth? – (Updated On: 28th-Oct-2026)

According to Strategic Market Research, the global Polyvinylpyrrolidone (PVP) Market is projected to reach USD 899.2 million by 2032, compared with an estimated USD 639.0 million in 2025. This represents a compound annual growth rate (CAGR) of 5.0% during 2026–2032, supported by the continued use of PVP as a tablet binder and drug solubilization agent, increasing requirements for specialized pharmaceutical-grade povidone, and its established applications in hair styling products, adhesives, coatings, and membrane manufacturing.

 

Pharmaceutical excipients remain the largest revenue-generating application for Polyvinylpyrrolidone, accounting for an estimated 48.2% of global market revenue in 2025. A significant development within this segment is the growing emphasis on controlling nitrite impurities in pharmaceutical ingredients. In 2025, BASF introduced Kollidon 30 NT, a nitrite-tested PVP grade supported by additional quality testing and documentation. This development directly addresses the need for greater control over potential nitrosamine formation in medicines, strengthening opportunities for pharmaceutical-grade PVP with enhanced quality assurance. (Source: BASF Pharma Solutions – Kollidon NT Grades, 2025)

 

Nanotechnology is creating additional specialized applications for Polyvinylpyrrolidone, particularly in the production of silver nanowires and nanoparticles. A 2024 study published in Scientific Reports demonstrated that selecting different PVP molecular weights helps control silver nanowire formation for transparent conductive electrodes. Such research supports the use of PVP in developing conductive materials for electronic applications. These applications represent a specialized opportunity for Polyvinylpyrrolidone beyond its established pharmaceutical and personal care markets. (Source: Scientific Reports – Silver Nanowire Research, September 2024)

 

Functional composites and biomedical materials represent another emerging area for Polyvinylpyrrolidone. Research published in December 2024 demonstrated the use of PVP combined with carrageenan to develop absorbent wound-dressing films, with experimental materials achieving 91.1% wound closure in animal testing. The findings highlight PVP's potential in advanced wound-care materials, although further development is required before such experimental applications translate into established market demand. These advances offer opportunities for specialty Polyvinylpyrrolidone formulations used in medical materials and functional polymer composites. (Source: International Journal of Biological Macromolecules – PVP-Based Wound Dressing Research, 2024)

 

Key Report Takeaways

By Polymer Grade

• Largest Subsegment – Medium K-Value PVP (K18–K60): Accounted for 55.9% of global revenue, equivalent to USD 357.0 million in 2025, with an estimated 4.6% CAGR during 2026–2032, supported by established K25 and K30 applications in pharmaceutical tablet binding and industrial formulations.

• Fastest-Growing Subsegment – Low K-Value PVP (K12–K17): Represented 23.5% of revenue, or USD 150.0 million in 2025, with a projected 6.8% CAGR, driven by pharmaceutical formulations requiring improved drug solubility and specialized low-molecular-weight povidone grades.

 

By Primary Application

• Largest Subsegment – Pharmaceutical Tablet Binding & Solid Dosage: Generated USD 225.0 million, accounting for 35.2% of global revenue in 2025, with an estimated 4.5% CAGR, supported by the continued use of PVP as a binder in oral solid medicines.

• Fastest-Growing Subsegment – Membrane Manufacturing: Contributed USD 45.0 million, representing 7.0% of the market in 2025, with a projected 7.4% CAGR, driven by PVP use as a pore-forming additive in selected filtration and separation membrane manufacturing processes.

 

By End-Use Industry

• Largest Subsegment – Pharmaceuticals: Led with 48.2% market share, generating USD 308.0 million in 2025, with an estimated 5.2% CAGR, supported by PVP requirements in tablet manufacturing and drug solubilization.

• Fastest-Growing Subsegment – Industrial Manufacturing: Accounted for 22.4% of market revenue, equivalent to USD 143.0 million in 2025, with a projected 5.8% CAGR, supported by specialized PVP applications in membrane fabrication, adhesives, coatings, and industrial processing.

 

By Region

• Largest Subsegment – Asia Pacific: Held 40.2% of global revenue, equivalent to USD 257.0 million in 2025, with an estimated 5.8% CAGR, supported by PVP manufacturing in China and Japan and demand from regional pharmaceutical and specialty formulation industries.

• Fastest-Growing Subsegment – Middle East & Africa: Represented 5.2% of global revenue, or USD 33.0 million in 2025, with a projected 7.1% CAGR, reflecting expected growth in pharmaceutical formulation and specialty chemical applications across selected regional markets.

 

Recent Developments in the Polyvinylpyrrolidone Market

• March 2, 2026: Nanjing Shundajie Chemical New Materials reported a manufacturing and export cooperation agreement following a visit by an Indian delegation on April 22–23, 2025. The delegation inspected the company's PVP K30 and povidone-iodine production lines, assessed manufacturing quality, and placed an order. The agreement highlights cross-border trade opportunities for Chinese Polyvinylpyrrolidone manufacturers serving India's pharmaceutical and personal care industries. (Source: Nanjing Sundge Chemical – Official Company Announcement)

• February 3, 2026: Ashland confirmed the launch of its Plasdone low-nitrite povidone grades during its first-quarter fiscal 2026 earnings discussion. The company reported positive market reception from pharmaceutical manufacturers seeking excipients with controlled nitrite levels to manage nitrosamine-related quality requirements. This development strengthens the position of specialized pharmaceutical-grade Polyvinylpyrrolidone in regulated drug formulations. (Source: Ashland – Q1 FY2026 Earnings Call Transcript, Company Investor Relations)

 

Why Does Medium K-Value Polyvinylpyrrolidone Account for the Largest Market Share?

Medium K-Value Polyvinylpyrrolidone (K18–K60) led the global market with an estimated 55.9% share, generating USD 357.0 million in 2025, according to Strategic Market Research. K25 and K30 are the leading grades within this segment, particularly in pharmaceutical tablet manufacturing, where PVP helps bind ingredients together and maintain tablet strength. According to BASF's 2025 technical documentation, Kollidon 25 and 30 are used in tablet binding, drug solubilization, and suspension stabilization. Their established use across multiple pharmaceutical manufacturing processes supports the medium K-value segment's leading revenue position.

Low K-Value Polyvinylpyrrolidone (K12–K17) accounted for approximately USD 150.0 million, representing 23.5% of global revenue in 2025. These grades serve specialized pharmaceutical formulations, particularly where PVP improves the dissolution of poorly soluble drugs. Ashland's pharmaceutical product documentation confirms the use of its Plasdone PVP grades in drug solubilization and solid-dispersion formulations. Such applications support demand for low K-value PVP in pharmaceutical products requiring improved drug delivery.

High K-Value Polyvinylpyrrolidone (Above K60) represented USD 132.0 million, or 20.7% of market revenue in 2025. K90 and related grades are used in hair styling products, pharmaceutical binders, and specialty industrial formulations. Nippon Shokubai's PVP product documentation confirms the use of high K-value PVP in hair care products for stronger film formation and hair adhesion. These applications support the segment's position in hair styling and specialized formulations where stronger binding performance is required.

 

Why Does Pharmaceutical Tablet Manufacturing Lead the Polyvinylpyrrolidone Market?

Pharmaceutical tablet binding and solid dosage formulations led the Polyvinylpyrrolidone Market with an estimated revenue of USD 225.0 million in 2025, accounting for 35.2% of global revenue, according to Strategic Market Research. PVP is widely used as a binder in pharmaceutical tablets because it holds powdered ingredients together during manufacturing and helps maintain tablet strength. According to JRS Pharma, PVP K25 and K30 are typically used at concentrations of 4–7% and 2–5%, respectively, in relevant tablet formulations. These established applications support recurring demand for pharmaceutical-grade Polyvinylpyrrolidone in solid oral medicines.

Pharmaceutical solubilization and other dosage forms contributed an estimated USD 83.0 million, representing 13.0% of global PVP revenue in 2025. This segment includes medicines where PVP helps poorly soluble active ingredients dissolve more effectively. Ashland's Plasdone Povidone portfolio also covers specialized grades for drug formulations requiring controlled nitrite levels and improved stability. Together, pharmaceutical applications generated approximately USD 308.0 million, representing 48.2% of the global Polyvinylpyrrolidone Market, highlighting the importance of tablet manufacturing and specialized drug formulations to industry revenue.

 

How Important Are Hair Styling and Personal Care Applications in the Polyvinylpyrrolidone Market?

Hair styling products accounted for an estimated USD 95.0 million, representing 14.9% of the global Polyvinylpyrrolidone Market in 2025, according to Strategic Market Research. Hair sprays, styling gels, and mousses use PVP to provide hair hold, maintain hairstyles, and form a film around hair strands. BASF's Luviskol K30 product portfolio confirms its use in hair gels, creams, mousses, and styling sprays. These applications support demand for PVP grades that provide different levels of hair hold and styling performance.

Other cosmetics and personal care applications generated an estimated USD 33.0 million, accounting for 5.2% of global revenue in 2025. Beyond conventional styling products, PVP is also used in specialized hair care formulations. Ashland's Advantage Revive polymer, which uses PVP chemistry, is designed for dry shampoos and related products to help remove excess oil while reducing visible residue. Together, hair styling and other personal care applications represented USD 128.0 million, or 20.0% of the global Polyvinylpyrrolidone Market, reflecting the polymer's role in both everyday styling products and specialized hair care formulations.

 

What Role Do Adhesives, Coatings, and Membrane Manufacturing Play?

Adhesives and coatings generated approximately USD 68.0 million in 2025, representing 10.6% of global Polyvinylpyrrolidone revenue. PVP serves as a binding, dispersing, and film-forming ingredient in selected industrial formulations, with consumption linked to the use of PVP-based systems in specialty manufacturing.

Membrane manufacturing contributed USD 45.0 million, or 7.0% of the market. Soluble PVP is used as a processing additive in certain membrane manufacturing processes, including polymeric filtration membranes. Its consumption is linked to the production of membrane materials incorporating PVP during fabrication.

Other industrial processing applications contributed another USD 30.0 million, taking the industrial manufacturing segment to USD 143.0 million, or 22.4% of global revenue. Estimated industrial consumption reached approximately 26,000 metric tonnes in 2025, making it the largest end-use group by physical volume.

Oral care formulations generated approximately USD 28.0 million, supported by the use of PVP in selected toothpaste and related formulations. Other specialty applications contributed USD 32.0 million, completing the global application assessment.

 

Why Does Asia Pacific Lead the Global Polyvinylpyrrolidone Market?

Asia Pacific led the global Polyvinylpyrrolidone Market with an estimated USD 257.0 million in revenue in 2025, accounting for 40.2% of the global market, according to Strategic Market Research. The region's leading position reflects established PVP manufacturing in China and Japan, alongside its use in pharmaceutical formulations, cosmetics, and specialty industrial materials.

China led the global Polyvinylpyrrolidone Market with an estimated revenue of USD 95.0 million in 2025, accounting for 14.9% of global demand, according to Strategic Market Research. China's position is supported by its expanding domestic PVP manufacturing capabilities and demand for the polymer in pharmaceutical formulations, personal care products, and specialty industrial applications. In August 2024, Chinese manufacturer Boai NKY reported that its PVP-related sales volume increased by more than 30% during the first half of 2024 compared with the same period in 2023, with particularly strong growth in cross-linked PVP (PVPP) and PVP used in new-energy applications. The company also disclosed an annualized PVP production capacity exceeding 20,000 metric tonnes and plans for an additional 10,000-tonne pharmaceutical-grade PVP production line. These developments highlight increasing demand for specialized PVP products and investment in higher-quality pharmaceutical materials, strengthening China's role in global Polyvinylpyrrolidone manufacturing. (Source: Boai NKY – August 2024 Investor Relations Disclosure)

China's pharmaceutical-grade PVP manufacturing capabilities are further supported by international chemical producers. BASF's 2024 Greater China report confirmed that Polyvinylpyrrolidone K30 was among the products manufactured at its Shanghai Pudong facility. K30 is widely used in pharmaceutical tablet binding and other drug formulations, making local manufacturing relevant to China's pharmaceutical excipient industry. BASF's continued PVP production in Shanghai, alongside domestic manufacturers expanding their pharmaceutical-grade portfolios, demonstrates China's established position in both conventional and specialized Polyvinylpyrrolidone production. (Source: BASF – Greater China Report 2024)

Japan represented approximately USD 31.0 million, or 4.9% of global Polyvinylpyrrolidone revenue in 2025. Japan's chemical manufacturers serve PVP applications in cosmetics, electronic materials, adhesives, and membrane production. According to Japan's National Institute of Technology and Evaluation (NITE), the country's reported manufacturing and import quantity for Polyvinylpyrrolidone fell within the 1,000–2,000 metric tonne reporting band in fiscal 2024, confirming measurable activity in the domestic PVP market. Nippon Shokubai's PVP portfolio further demonstrates Japanese manufacturing expertise across specialty applications, including semiconductors and filtration membranes.

South Korea accounted for an estimated USD 26.0 million, representing 4.1% of global revenue in 2025. Polyvinylpyrrolidone serves the country's cosmetic and specialty formulation industries, particularly hair styling products requiring film formation and lasting hold. South Korean cosmetics company TONYMOLY lists PVP among its cosmetic ingredients and describes its role in hair styling and skin care formulations, providing direct evidence of the polymer's relevance to Korean personal care manufacturing.

India contributed approximately USD 48.0 million, equivalent to 7.5% of global Polyvinylpyrrolidone revenue in 2025. Pharmaceutical formulations represent an important application for PVP in India, particularly in oral solid dosage manufacturing. Demand is supported by the use of pharmaceutical-grade povidone as a tablet binder and formulation ingredient, making pharmaceutical excipients an important part of the country's PVP market.

 

How Does North America Compare with Other Regions in the Polyvinylpyrrolidone Market?

North America generated an estimated USD 125.0 million in Polyvinylpyrrolidone revenue in 2025, accounting for 19.6% of the global market, according to Strategic Market Research. The United States was the region's largest market, contributing approximately USD 88.0 million, or 13.8% of global revenue. Pharmaceutical formulations represent an important source of demand, particularly medicines that use PVP to bind tablet ingredients, improve drug dissolution, or maintain formulation stability.

Recent US regulatory documentation provides direct evidence of Polyvinylpyrrolidone's continued role in pharmaceutical development. In February 2024, the US Food and Drug Administration (FDA) completed its review of Legubeti, an acetylcysteine oral formulation containing povidone as an excipient. The review evaluated PVP exposure and its suitability for the proposed medicine, demonstrating the polymer's role in pharmaceutical formulations beyond conventional tablets. This supports the importance of pharmaceutical-grade Polyvinylpyrrolidone within the US market. (Source: FDA, February 2024 Drug Review)

Beyond pharmaceuticals, Polyvinylpyrrolidone serves personal care and specialty industrial applications in North America. The US FDA's food-substance database also lists PVP for formulation, processing, stabilization, and thickening functions, confirming its use across additional regulated applications. These established applications provide multiple sources of demand for Polyvinylpyrrolidone across the region. (Source: US FDA – Polyvinylpyrrolidone Substance Database)

 

What Supports Polyvinylpyrrolidone Demand Across Europe?

Europe accounted for an estimated USD 165.0 million in Polyvinylpyrrolidone revenue in 2025, representing 25.8% of the global market, according to Strategic Market Research. Germany led the region with approximately USD 33.0 million, equivalent to 5.2% of global revenue. Germany's position is supported by established pharmaceutical-grade PVP manufacturing and demand from medicine producers using povidone in tablet formulations. Recent manufacturer documentation provides evidence of Germany's specialization in pharmaceutical PVP. BASF's updated Kollidon portfolio includes German-manufactured PVP K30 and a separately tested K30 NT grade designed for pharmaceutical applications requiring tighter nitrite control. This strengthens Germany's position in the European market for specialized Polyvinylpyrrolidone used in medicine manufacturing. (Source: BASF – Kollidon PVP Product Portfolio)

Pharmaceutical quality requirements are an important factor shaping Polyvinylpyrrolidone demand across Europe. The European Medicines Agency's guidance, updated in October 2025, requires pharmaceutical companies to assess and control nitrosamine risks in medicines, including risks associated with formulation ingredients. For PVP-based medicines, these requirements increase the importance of carefully controlled excipient quality and documented impurity levels. France contributed an estimated USD 21.0 million, followed by the United Kingdom at USD 19.0 million and Italy at USD 18.0 million in 2025. Pharmaceutical tablet production, drug solubilization, and selected personal care formulations remain important applications for Polyvinylpyrrolidone across these European markets.

 

What Is the Market Position of Latin America and the Middle East?

Latin America accounted for approximately USD 43.0 million, or 6.7% of global PVP revenue in 2025. Brazil represented USD 23.0 million, supported by demand for pharmaceutical excipients, cosmetics, and selected industrial formulations.

The Middle East & Africa generated an estimated USD 33.0 million, representing 5.2% of global revenue. Pharmaceutical production and specialty formulation activities provide the principal identified applications for PVP across these markets.

 

Who Are the Leading Polyvinylpyrrolidone Manufacturers?

The global Polyvinylpyrrolidone industry includes several established specialty chemical manufacturers with distinct pharmaceutical and industrial product portfolios.

Key companies include BASF, Ashland, Boai NKY, JRS Pharma, Nippon Shokubai, Henan Pengfei New Materials, and Hangzhou Weitong Nanomaterials.

BASF's Kollidon portfolio is positioned toward pharmaceutical formulations, while Ashland's Plasdone products serve tablet manufacturing and drug formulation requirements. JRS Pharma markets VIVAPHARM PVP grades for pharmaceutical excipient applications.

Chinese producers contribute to industrial and pharmaceutical PVP availability through K-series products and specialty polymer portfolios. Competition across the market is shaped by pharmaceutical quality requirements, product consistency, manufacturing scale, and access to regional formulation industries.

 

How Was the Polyvinylpyrrolidone Market Estimated?

Strategic Market Research evaluates the Polyvinylpyrrolidone Market through a triangulated, bottom-up methodology combining manufacturer production capacity, estimated operating output, downstream application consumption, and grade-specific realized pricing.

The assessment measures demand for soluble PVP across pharmaceutical formulations, personal care, adhesives, coatings, membrane manufacturing, oral care, and specialty industrial processing. Consumption estimates incorporate polymer-grade requirements, formulation usage, and regional manufacturing activity.

Market revenue is developed using application-specific and country-level pricing assessments, supported by manufacturer product portfolios, capacity disclosures, and available transaction benchmarks. Polymer-grade, application, and geographic estimates are reconciled to maintain consistent global market coverage and avoid duplication.

The 2026–2032 forecast incorporates pharmaceutical formulation demand, adoption of specialty PVP grades, personal care applications, industrial processing requirements, manufacturing capacity, and regional pricing conditions. All market values, consumption volumes, shares, and forecasts represent Strategic Market Research estimates, with manufacturer disclosures serving as primary industry evidence.

 

Polyvinylpyrrolidone Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026–2032
Market Size Value in 2025	USD 639.0 Million
Revenue Forecast in 2032	USD 899.2 Million
Overall Growth Rate	5.0% CAGR
Base Year for Estimation	2025
Historical Data	2019–2024
Unit	USD Million, CAGR (2026–2032)
Segmentation	By Polymer Grade; By Primary Application; By End-Use Industry; By Geography
By Polymer Grade	Low K-Value PVP [K12–K17], Medium K-Value PVP [K18–K60], High K-Value PVP [Above K60]
By Primary Application	Pharmaceutical Tablet Binding & Solid Dosage, Pharmaceutical Solubilization & Other Dosage Forms, Hair Styling Products, Other Personal Care & Cosmetics, Adhesives & Coatings, Membrane Manufacturing, Other Industrial Processing, Oral Care Formulations, Other Specialty Applications
By End-Use Industry	Pharmaceuticals, Personal Care & Cosmetics, Industrial Manufacturing, Other Specialty End Uses
By Region	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country Scope	China, Japan, South Korea, India, United States, Germany, France, United Kingdom, Italy, Brazil
Market Drivers	This represents a compound annual growth rate (CAGR) of approximately 5.0% during 2026–2032, supported by the continued use of PVP as a tablet binder and drug solubilization agent, increasing requirements for specialized pharmaceutical-grade povidone, and its established applications in hair styling products, adhesives, coatings, and membrane manufacturing.
Customization Option	Available upon request